Medtronic (MDT) Q1 FY2026 earnings: revenue $8.6 billion, up 8.4% on the year
Medtronic plc (MDT) reported revenue of $8.6 billion for Q1 FY2026, the quarter ended 25 July 2025, up 8.4% on the same quarter a year earlier. Net income was $1.0 billion, down 0.2% on the year, and diluted earnings per share $0.81. The figures are the company's own, from the 10-Q it filed with the SEC on 26 August 2025.
Revenue
$8.6 billion
+8.4% on the year · -3.9% on the quarter
Q2 FY2024Q1 FY2026
Operating margin
16.8%
16.1% a year earlier
Q2 FY2024Q1 FY2026
Net income
$1.0 billion
-0.2% on the year · -1.5% on the quarter
Q2 FY2024Q1 FY2026
Diluted EPS
$0.81
+1.3% on the year · -1.2% on the quarter
Q2 FY2024Q1 FY2026
this quarterthe same quarter a year earlierHover a bar for its figure.
Income statement (profit and loss)
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Revenue
8,578
8,927
7,915
-3.9%
+8.4%
Cost of revenue
3,001
3,146
2,761
-4.6%
+8.7%
Gross profit
5,577
5,781
5,154
-3.5%
+8.2%
Gross margin
65.0%
64.8%
65.1%
Research and development
726
684
676
+6.1%
+7.4%
Selling, general and administrative
2,806
2,720
2,655
+3.2%
+5.7%
Operating income
1,445
1,436
1,278
+0.6%
+13.1%
Operating margin
16.8%
16.1%
16.1%
Interest expense
176
174
167
+1.1%
+5.4%
Pre-tax income
1,302
1,261
1,268
+3.3%
+2.7%
Income tax
255
198
220
+28.8%
+15.9%
Effective tax rate
19.6%
15.7%
17.4%
Net income
1,040
1,056
1,042
-1.5%
-0.2%
Net margin
12.1%
11.8%
13.2%
Diluted EPS
$0.81
$0.82
$0.80
-1.2%
+1.3%
$ million except per share. Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Operating cash flow
1,088
2,528
986
-57.0%
+10.3%
Capital expenditure
504
459
520
+9.8%
-3.1%
Free cash flow
584
2,069
466
-71.8%
+25.3%
Free cash flow margin
6.8%
23.2%
5.9%
Cash from investing
-719
-490
-259
Cash from financing
-1,381
-1,343
-731
Depreciation and amortisation
748
840
662
-11.0%
+13.0%
Share-based compensation
86.0
89.0
83.0
-3.4%
+3.6%
Buybacks
123
274
2,492
-55.1%
-95.1%
Dividends paid
910
897
898
+1.4%
+1.3%
Dividend per share
$0.71
n/a
$0.70
+1.4%
Diluted shares, weighted
1,287m
1,288m
1,296m
-0.0%
-0.7%
Shares outstanding at period end
1,282m
1,282m
1,282m
-0.0%
-0.0%
Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.
Balance sheet
$ million
Q1 FY2026
Q4 FY2025
Q1 FY2025
On the quarter
On the year
Last 8 quarters
Shareholders' equity
47,893
48,024
47,947
-0.3%
-0.1%
Non-controlling interest
240
232
213
+3.4%
+12.7%
Debt
28,609
28,516
27,865
+0.3%
+2.7%
Operating lease liabilities
n/a
918
n/a
Finance lease liabilities
51.0
52.0
52.0
-1.9%
-1.9%
Other liabilities
14,179
13,938
13,672
+1.7%
+3.7%
Total liabilities and equity
90,972
91,680
89,749
-0.8%
+1.4%
Fixed assets
7,006
6,837
6,282
+2.5%
+11.5%
Goodwill
42,007
41,737
41,084
+0.6%
+2.2%
Intangible assets
11,223
11,667
12,819
-3.8%
-12.5%
Investments
6,848
6,747
6,532
+1.5%
+4.8%
Cash and equivalents
1,273
2,218
1,311
-42.6%
-2.9%
Receivables
6,263
6,515
6,011
-3.9%
+4.2%
Inventory
5,886
5,476
5,414
+7.5%
+8.7%
Other assets
10,466
10,483
10,296
-0.2%
+1.7%
Total assets
90,972
91,680
89,749
-0.8%
+1.4%
Questions
What was Medtronic's revenue in Q1 FY2026?
Medtronic (MDT) reported revenue of $8.6 billion for Q1 FY2026, the quarter ended 25 July 2025, up 8.4% on the same quarter a year earlier.
How much did Medtronic earn in Q1 FY2026?
Net income for Q1 FY2026 was $1.0 billion, down 0.2% on the year, and diluted earnings per share $0.81.
When did Medtronic report Q1 FY2026 results?
Medtronic filed its 10-Q for the quarter ended 25 July 2025 with the SEC on 26 August 2025.
Each quarter as filed, linked to its filing. Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.
10-Q for the period ended 25 July 2025, filed 26 August 2025: the filing.